BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 2680140)

  • 1. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79.
    Bagshawe A; Scott GC; Russell DA; Wigley SC; Merianos A; Berry G
    Bull World Health Organ; 1989; 67(4):389-99. PubMed ID: 2680140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCG vaccination protects against leprosy in Venezuela: a case-control study.
    Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG vaccination of children against leprosy: nine-year findings of the controlled WHO trial in Burma.
    Bechelli LM; Lwin K; Gallego Garbajosa P; Mg-Mg-Gyi ; Uemura K; Sundaresan T; Tamondong C; Matejka M; Sansarricq H; Walter J
    Bull World Health Organ; 1974; 51(1):93-9. PubMed ID: 4281729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma.
    Bechelli LM; Garbajosa PG; Gyi MM; Uemura K; Sundaresan T; Martínez Domínguez V; Matejka M; Tamondong C; Quagliato R; Engler V; Altmann M
    Bull World Health Organ; 1973; 48(3):323-34. PubMed ID: 4270384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculin sensitivity and skin lesions in children after vaccination with two batches of BCG vaccine.
    Vallishayee RS; Anantharaman DS; Gupte MD
    Indian J Lepr; 1998; 70(3):277-86. PubMed ID: 9801900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon.
    Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM
    Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of intradermal BCG against leprosy; a case-control study in central Brazil.
    Rodrigues ML; Silva SA; Neto JC; de Andrade AL; Martelli CM; Zicker F
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):335-9. PubMed ID: 1474274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long lasting BCG protection against leprosy.
    Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML
    Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does BCG vaccination protect the newborn and young infants?
    ten Dam HG; Hitze KL
    Bull World Health Organ; 1980; 58(1):37-41. PubMed ID: 6991146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative leprosy vaccine trial in south India.
    Gupte MD; Vallishayee RS; Anantharaman DS; Nagaraju B; Sreevatsa ; Balasubramanyam S; de Britto RL; Elango N; Uthayakumaran N; Mahalingam VN; Lourdusamy G; Ramalingam A; Kannan S; Arokiasamy J
    Indian J Lepr; 1998; 70(4):369-88. PubMed ID: 10189587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG vaccination of children against leprosy: fourteen-year findings of the trial in Burma.
    Lwin K; Sundaresan T; Gyi MM; Bechelli LM; Tamondong C; Garbajosa PG; Sansarricq H; Noordeen SK
    Bull World Health Organ; 1985; 63(6):1069-78. PubMed ID: 2940028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
    Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence rates of leprosy in Karonga District, northern Malawi: patterns by age, sex, BCG status and classification.
    Pönnighaus JM; Fine PE; Sterne JA; Bliss L; Wilson RJ; Malema SS; Kileta S
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):10-23. PubMed ID: 8189075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG vaccination of children against leprosy in Uganda: final results.
    Stanley SJ; Howland C; Stone MM; Sutherland I
    J Hyg (Lond); 1981 Oct; 87(2):233-48. PubMed ID: 7288177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG vaccination in leprosy.
    Price JE
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):205-12. PubMed ID: 6749707
    [No Abstract]   [Full Text] [Related]  

  • 16. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
    Velema JP; Ogbeiwi OI
    Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for B.C.G.
    Tripathy SP
    Ann Natl Acad Med Sci; 1983; 19(1):11-21. PubMed ID: 12341889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of BCG vaccination among leprosy contacts: a cohort study.
    Düppre NC; Camacho LA; da Cunha SS; Struchiner CJ; Sales AM; Nery JA; Sarno EN
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):631-8. PubMed ID: 18514242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on BCG vaccination.
    ten Dam HG
    Adv Tuberc Res; 1984; 21():79-106. PubMed ID: 6433675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya.
    Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):542-9. PubMed ID: 8151184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.